Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

284.47
-4.7800-1.65%
Post-market: 283.22-1.2500-0.44%17:17 EDT
Volume:261.16K
Turnover:74.59M
Market Cap:5.67B
PE:29.30
High:294.00
Open:291.48
Low:283.77
Close:289.25
52wk High:326.63
52wk Low:161.82
Shares:19.94M
Float Shares:19.35M
Volume Ratio:1.31
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):9.71
EPS(LYR):6.13
ROE:21.96%
ROA:3.99%
PB:5.86
PE(LYR):46.41

Loading ...

Press Release: Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets

Dow Jones
·
Jul 14

Agenus Signs Deal to Sell Up to $340 Million Worth of Securities; Shares Up Pre-Bell

MT Newswires Live
·
Jul 13

Ligand Pharmaceuticals is Maintained at Buy by B of a Securities

Dow Jones
·
Jul 09

Ligand Pharmaceuticals : Bofa Global Research Raises Price Objective to $388.00 from $266.00

THOMSON REUTERS
·
Jul 09

Ligand price target raised to $388 from $266 at BofA

TIPRANKS
·
Jul 09

Ligand Pharmaceuticals Inc : Stifel Raises Target Price to $332 from $255

THOMSON REUTERS
·
Jul 08

Ligand CLO, Secretary Andrew Reardon Disposes of Common Shares Worth $1.53 Million

Reuters
·
Jul 07

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Mesoblast Limited (OtherMEOBF) and Cogstate Ltd (OtherCOGZF)

TIPRANKS
·
Jul 02

Is Ligand (LGND) Using Zero-Coupon Converts to Quietly Redefine Its Capital Allocation Playbook?

Simply Wall St.
·
Jun 29

Ligand Closes USD 700 Million 0% Convertible Senior Notes Offering Due 2031

Reuters
·
Jun 26

Press Release: Ligand Announces Closing of Convertible Senior Notes Offering

Dow Jones
·
Jun 26

BUZZ-Ligand Pharma slips after upsized $625 mln convertible debt offering

Reuters
·
Jun 23

Ligand prices upsized $625M convertible senior note offering

TIPRANKS
·
Jun 23

Ligand Pharmaceuticals Prices Upsized $625 Million Convertible Notes Offering

MT Newswires Live
·
Jun 23

Ligand Pharmaceuticals Shares Drop After Plans to Offer $550M in Notes

Dow Jones
·
Jun 22

BUZZ-Ligand Pharma eases from record on $550 mln convertible debt deal

Reuters
·
Jun 22

BRIEF-Ligand Announces Proposed Offering Of $550 Million Of Convertible Senior Notes Due 2031

Reuters
·
Jun 22

Ligand proposes offering USD 550 million of convertible senior notes due 2031

Reuters
·
Jun 22

Ligand Pharmaceuticals - Initial Purchasers Granted 13-Day Option to Buy up to $82.5 Mln Additional Notes

THOMSON REUTERS
·
Jun 22

Ligand Announces Proposed Offering of $550 Million of Convertible Senior Notes Due 2031

THOMSON REUTERS
·
Jun 22